New draft guidance published by the US Food and Drug Administration (FDA) is intended to aid clinical study design in psychedelic drug development programmes.
US...
First guidance in this area from the Agency addresses the unique challenges when designing clinical studies for these drugsThe FDA published its first draft...
SILVER SPRING, Md., June 23, 2023. Today, the U.S. Food and Drug Administration published a new draft guidance to highlight fundamental considerations to...
California is one step closer to legalizing psychedelics. A State Senate committee approved a bill that legalizes possessing certain psychedelic substances.The bill looks to...
Plant-based medicines and therapeutics finally are gaining significant traction with the medical establishment. After decades of closed-mindedness, it’s about time.
However, the bright spotlight on...
There has been a resurgence in the debate about the clinical use of Psychedelic therapies or psychedelic-assisted psychotherapy (PAP). There’s been increased legalization of...
LOS ANGELES —
People Science, a direct-to-consumer scientific research company providing a scaled research and development (R&D) platform for alternative medicines, today announced $5.3 million in...
Mental health diagnoses, including depression, anxiety, post-traumatic stress disorder (PTSD), and addiction, are increasing in worldwide prevalence across all regions, ethnicities, religions, social circles,...
Cannabis is a psychedelic drug being increasingly legalized throughout the western world for medicinal and recreational purposes. Simultaneously, more potent drug preparations are being...
